These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33139933)

  • 21. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines.
    Hu H; Yang C; Zhang F; Li M; Tu Z; Mu L; Dawulieti J; Lao YH; Xiao Z; Yan H; Sun W; Shao D; Leong KW
    Adv Sci (Weinh); 2021 Aug; 8(15):2002020. PubMed ID: 34386315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.
    Lv X; Huang J; Min J; Wang H; Xu Y; Zhang Z; Zhou X; Wang J; Liu Z; Zhao H
    J Control Release; 2023 May; 357():109-119. PubMed ID: 36738971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
    Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
    Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
    Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells.
    Verbeke R; Lentacker I; Breckpot K; Janssens J; Van Calenbergh S; De Smedt SC; Dewitte H
    ACS Nano; 2019 Feb; 13(2):1655-1669. PubMed ID: 30742405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-Mediated Remotely Controlled Nanovaccine Delivery for Tumor Vaccination and Individualized Cancer Immunotherapy.
    Meng Z; Zhang Y; She J; Zhou X; Xu J; Han X; Wang C; Zhu M; Liu Z
    Nano Lett; 2021 Feb; 21(3):1228-1237. PubMed ID: 33522825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A STING-activating nanovaccine for cancer immunotherapy.
    Luo M; Wang H; Wang Z; Cai H; Lu Z; Li Y; Du M; Huang G; Wang C; Chen X; Porembka MR; Lea J; Frankel AE; Fu YX; Chen ZJ; Gao J
    Nat Nanotechnol; 2017 Jul; 12(7):648-654. PubMed ID: 28436963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
    Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
    J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A General Strategy toward Self-assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses.
    Yu R; Jin L; Song Z; Jiao L; Wang Z; Zhou Y; Ma Y; Guan S; Zhang Z; Wang D; Liu H; Sun Y; Zhang S; Cai T; Sun H; Qiu Y; Miao J; Liu Z
    Small; 2024 Oct; 20(43):e2402792. PubMed ID: 38940386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acidity-responsive polyphenol-coordinated nanovaccines for improving tumor immunotherapy
    Qiu H; Wang S; Huang R; Liu X; Li L; Liu Z; Wang A; Ji S; Liang H; Jiang BP; Shen XC
    Biomater Sci; 2024 Jun; 12(12):3175-3192. PubMed ID: 38742916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy.
    Hu X; Wu T; Qin X; Qi Y; Qiao Q; Yang C; Zhang Z
    Adv Healthc Mater; 2019 Jan; 8(1):e1800837. PubMed ID: 30506847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ISCOM based vaccines for cancer immunotherapy.
    Lenarczyk A; Le TT; Drane D; Malliaros J; Pearse M; Hamilton R; Cox J; Luft T; Gardner J; Suhrbier A
    Vaccine; 2004 Feb; 22(8):963-74. PubMed ID: 15161073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
    Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chiral polypeptide nanoparticles as nanoadjuvants of nanovaccines for efficient cancer prevention and therapy.
    Su Y; Xu W; Wei Q; Ma Y; Ding J; Chen X
    Sci Bull (Beijing); 2023 Feb; 68(3):284-294. PubMed ID: 36732117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
    Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
    Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy.
    Luo L; Liu C; He T; Zeng L; Xing J; Xia Y; Pan Y; Gong C; Wu A
    Nanoscale; 2018 Nov; 10(46):22035-22043. PubMed ID: 30452049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomimetic Nanovaccines Potentiating Dendritic Cell Internalization via CXCR4-Mediated Macropinocytosis.
    Yang C; Zhang F; Chen F; Chang Z; Zhao Y; Shao D; Sun W; Dong WF; Wang Z
    Adv Healthc Mater; 2023 Feb; 12(5):e2202064. PubMed ID: 36416257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.